Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Innovative Medicines for Tuberculosis

Innovative Medicines for Tuberculosis?uq=UG6efJS6
2013 FOUNDED
PRIVATE STATUS
Grant LATEST DEAL TYPE
$750K LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of medicines for the treatment of tuberculosis. The company offers research and development services towards the causes of tuberculosis and its symptoms and also focuses on developing medicines to fight all forms of tuberculosis.

Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Services
Other Industries
Drug Discovery
Primary Office
  • EPFL Innovation Park
  • Building I
  • CH-1015 Lausanne
  • Switzerland

+41 021 000 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Innovative Medicines for Tuberculosis’s full profile, request a free trial.

Innovative Medicines for Tuberculosis Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 16-Mar-2015 $750K Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Innovative Medicines for Tuberculosis Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital Minority 000 0000 000000 0
EPFL Innovation Park Accelerator/Incubator 000 0000 000000 0

Innovative Medicines for Tuberculosis Executive Team (1)

Name Title Board
Seat
Contact
Info
Iain Old Operational Director

Innovative Medicines for Tuberculosis Board Members (6)

Name Representing Role Since Contact
Info
Gabriel Clerc Innovative Medicines for Tuberculosis Board Member 000 0000
Giampiero de Luca Innovative Medicines for Tuberculosis Board Member 000 0000
Laurent Nicod MD Innovative Medicines for Tuberculosis Board Member 000 0000
Stewart Cole Innovative Medicines for Tuberculosis Chairman of the Board 000 0000
Thierry Buclin Innovative Medicines for Tuberculosis Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »